Revere Asset Management Inc purchased a new stake in Direxion Daily S&P Biotech Bull 3X ETF (NYSEARCA:LABU – Free Report) during the second quarter, according to its most recent disclosure with the SEC. The firm purchased 2,279 shares of the company’s stock, valued at approximately $666,000. Direxion Daily S&P Biotech Bull 3X ETF makes up approximately 0.3% of Revere Asset Management Inc’s holdings, making the stock its 20th biggest holding.
Other institutional investors also recently bought and sold shares of the company. Foundations Investment Advisors LLC purchased a new stake in Direxion Daily S&P Biotech Bull 3X ETF during the 4th quarter worth approximately $797,000. SLT Holdings LLC purchased a new position in shares of Direxion Daily S&P Biotech Bull 3X ETF in the fourth quarter valued at approximately $797,000. Millennium Capital Advisors LLC purchased a new position in shares of Direxion Daily S&P Biotech Bull 3X ETF in the fourth quarter valued at approximately $648,000. Valued Retirements Inc. acquired a new stake in shares of Direxion Daily S&P Biotech Bull 3X ETF in the second quarter worth approximately $454,000. Finally, Halbert Hargrove Global Advisors LLC acquired a new stake in shares of Direxion Daily S&P Biotech Bull 3X ETF in the first quarter worth approximately $166,000.
Direxion Daily S&P Biotech Bull 3X ETF Stock Up 2.7%
Shares of LABU traded up $7.09 during trading hours on Monday, hitting $268.39. 212,468 shares of the stock were exchanged, compared to its average volume of 560,532. The stock’s 50-day moving average price is $282.15 and its two-hundred day moving average price is $219.50. Direxion Daily S&P Biotech Bull 3X ETF has a 12-month low of $74.95 and a 12-month high of $341.93.
Direxion Daily S&P Biotech Bull 3X ETF Profile
The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.
Further Reading
- Five stocks we like better than Direxion Daily S&P Biotech Bull 3X ETF
- Analysts Are Punting Their Calls Into the Next Quarter After Adobe’s Mixed Earnings
- Institutional Money Is Pouring Into These 2 Altcoin ETFs
- The End of Big Tech Buybacks? Only One Hyperscaler Is Still Repurchasing Shares
- 3 Dividend Kings to Buy While They’re Still Beaten Down
Want to see what other hedge funds are holding LABU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Direxion Daily S&P Biotech Bull 3X ETF (NYSEARCA:LABU – Free Report).
Receive News & Ratings for Direxion Daily S&P Biotech Bull 3X ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3X ETF and related companies with MarketBeat.com's FREE daily email newsletter.
